Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

Ítems similars

• A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
  per: Mookerjee, Ananda, et al.
  Publicat: (2018)
• IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine
  per: Mookerjee, Ananda, et al.
  Publicat: (2019)
• Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
  per: Kandalaft, Lana E., et al.
  Publicat: (2013)
• A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
  per: Kandalaft, Lana E, et al.
  Publicat: (2013)
• Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL
  per: Bialek-Waldmann, Julia K., et al.
  Publicat: (2021)